These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles]. Heidel G; Olbricht H; Ely K; Henkler J Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088 [No Abstract] [Full Text] [Related]
23. [Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination]. Colomer Pache M; Arnedo Pena A Med Clin (Barc); 1988 Nov; 91(17):649-52. PubMed ID: 3230970 [No Abstract] [Full Text] [Related]
24. [Incidence of measles in vaccinated children]. Duszczyk E; From M; Wojnarowski M Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):220. PubMed ID: 8234053 [No Abstract] [Full Text] [Related]
25. [Epidemiological characteristics of measles in mass vaccine prophylaxis and the prospects for its eradication]. Smorodintsev AA; Rykushin IuP; Smorodintsev AlA Tr Inst Im Pastera; 1982; 57():10-6. PubMed ID: 6221441 [No Abstract] [Full Text] [Related]
29. Problems in the eradication of measles. Riley HD South Med J; 1976 Sep; 69(9):1113-5. PubMed ID: 968521 [No Abstract] [Full Text] [Related]
30. The epidemiology and nature of measles in Nairobi before the impact of measles immunization. Hayden RJ East Afr Med J; 1974 Feb; 51(2):199-205. PubMed ID: 4837256 [No Abstract] [Full Text] [Related]
31. Epidemiology of measles in the vaccination era: implications for an effective prevention of the disease. Swartz TA Isr J Med Sci; 1991 Jan; 27(1):48-50. PubMed ID: 1995501 [No Abstract] [Full Text] [Related]
32. Supplementary immunization activities to achieve measles elimination: experience of the European Region. Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology and prevention of measles. Atkinson WL Dermatol Clin; 1995 Jul; 13(3):553-9. PubMed ID: 7554503 [TBL] [Abstract][Full Text] [Related]
34. [Patient factors in the failure of preventive measles vaccination (epidemiologic observations)]. Giesecke H Padiatr Grenzgeb; 1987; 26(6):447-8. PubMed ID: 3502021 [No Abstract] [Full Text] [Related]
35. [Methodological approaches to the dynamic assessment of the epidemic process in measles during years of vaccine prevention]. Borovskiĭ IV; Basova LS Tr Inst Im Pastera; 1985; 62():58-64. PubMed ID: 3843364 [No Abstract] [Full Text] [Related]
36. [The evolution of measles morbidity and mortality in Romania after the introduction of antimeasles vaccination]. Cazacu E; Bălan A; Dinică V Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):35-44. PubMed ID: 7981527 [No Abstract] [Full Text] [Related]
37. The heterogeneity of measles epidemiology in India: implications for improving control measures. Murhekar MV; Hutin YJ; Ramakrishnan R; Ramachandran V; Biswas AK; Das PK; Gupta SN; Maji D; Martolia HC; Mohan A; Gupte MD J Infect Dis; 2011 Jul; 204 Suppl 1():S421-6. PubMed ID: 21666194 [TBL] [Abstract][Full Text] [Related]
38. Field evaluation of measles vaccine efficacy in Najafgarh zone of delhi. Sharma RS; Chawla U; Datta KK J Commun Dis; 1988 Mar; 20(1):38-43. PubMed ID: 3230287 [No Abstract] [Full Text] [Related]